257 related articles for article (PubMed ID: 33386451)
1. The role of apparent diffusion coefficient value in the diagnosis of localized type 1 autoimmune pancreatitis: differentiation from pancreatic ductal adenocarcinoma and evaluation of response to steroids.
Sekito T; Ishii Y; Serikawa M; Tsuboi T; Kawamura R; Tsushima K; Nakamura S; Hirano T; Fukiage A; Mori T; Ikemoto J; Kiyoshita Y; Saeki S; Tamura Y; Miyamoto S; Chayama K
Abdom Radiol (NY); 2021 May; 46(5):2014-2024. PubMed ID: 33386451
[TBL] [Abstract][Full Text] [Related]
2. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma.
Jia H; Li J; Huang W; Lin G
BMC Med Imaging; 2021 Oct; 21(1):149. PubMed ID: 34654379
[TBL] [Abstract][Full Text] [Related]
3. Effective apparent diffusion coefficient parameters for differentiation between mass-forming autoimmune pancreatitis and pancreatic ductal adenocarcinoma.
Ren H; Mori N; Hamada S; Takasawa C; Mugikura S; Masamune A; Takase K
Abdom Radiol (NY); 2021 Apr; 46(4):1640-1647. PubMed ID: 33037891
[TBL] [Abstract][Full Text] [Related]
4. Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings.
Choi SY; Kim SH; Kang TW; Song KD; Park HJ; Choi YH
AJR Am J Roentgenol; 2016 Feb; 206(2):291-300. PubMed ID: 26797355
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI.
Kamisawa T; Takuma K; Anjiki H; Egawa N; Hata T; Kurata M; Honda G; Tsuruta K; Suzuki M; Kamata N; Sasaki T
Am J Gastroenterol; 2010 Aug; 105(8):1870-5. PubMed ID: 20216538
[TBL] [Abstract][Full Text] [Related]
6. MRI features for differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
Ha J; Choi SH; Kim KW; Kim JH; Kim HJ
Dig Liver Dis; 2022 Jul; 54(7):849-856. PubMed ID: 34903501
[TBL] [Abstract][Full Text] [Related]
7. Optimal target b-value on computed diffusion-weighted magnetic resonance imaging for visualization of pancreatic ductal adenocarcinoma and focal autoimmune pancreatitis.
Ichikawa S; Kromrey ML; Motosugi U; Onishi H
Abdom Radiol (NY); 2021 Feb; 46(2):636-646. PubMed ID: 32740865
[TBL] [Abstract][Full Text] [Related]
8. Radiomics based on diffusion-weighted imaging for differentiation between focal-type autoimmune pancreatitis and pancreatic carcinoma.
Shiraishi M; Igarashi T; Hiroaki F; Oe R; Ohki K; Ojiri H
Br J Radiol; 2022 Dec; 95(1140):20210456. PubMed ID: 35946923
[TBL] [Abstract][Full Text] [Related]
9. Intravoxel incoherent motion diffusion-weighted imaging of the pancreas: Characterization of benign and malignant pancreatic pathologies.
Kim B; Lee SS; Sung YS; Cheong H; Byun JH; Kim HJ; Kim JH
J Magn Reson Imaging; 2017 Jan; 45(1):260-269. PubMed ID: 27273754
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of CT and MRI for differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma.
Ha J; Choi SH; Byun JH; Kim KW; Kim SY; Kim JH; Kim HJ
Eur Radiol; 2021 May; 31(5):3427-3438. PubMed ID: 33146798
[TBL] [Abstract][Full Text] [Related]
11. Intravoxel incoherent motion magnetic resonance imaging for differentiating metastatic and non-metastatic lymph nodes in pancreatic ductal adenocarcinoma.
Rong D; Mao Y; Hu W; Xu S; Wang J; He H; Li S; Zhang R
Eur Radiol; 2018 Jul; 28(7):2781-2789. PubMed ID: 29404768
[TBL] [Abstract][Full Text] [Related]
12. The use of magnetic resonance elastography in differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A preliminary study.
Shi Y; Cang L; Zhang X; Cai X; Wang X; Ji R; Wang M; Hong Y
Eur J Radiol; 2018 Nov; 108():13-20. PubMed ID: 30396645
[TBL] [Abstract][Full Text] [Related]
13. Multifocal autoimmune pancreatitis: A retrospective study in a single tertiary center of 26 patients with a 20-year literature review.
Huang XM; Shi ZS; Ma CL
World J Gastroenterol; 2021 Jul; 27(27):4429-4440. PubMed ID: 34366614
[TBL] [Abstract][Full Text] [Related]
14. Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features.
Park S; Chu LC; Hruban RH; Vogelstein B; Kinzler KW; Yuille AL; Fouladi DF; Shayesteh S; Ghandili S; Wolfgang CL; Burkhart R; He J; Fishman EK; Kawamoto S
Diagn Interv Imaging; 2020 Sep; 101(9):555-564. PubMed ID: 32278586
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma.
Yoon SB; Jeon TY; Moon SH; Lee SM; Kim MH
Eur Radiol; 2022 Oct; 32(10):6691-6701. PubMed ID: 35486167
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of focal autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Lopes Vendrami C; Shin JS; Hammond NA; Kothari K; Mittal PK; Miller FH
Abdom Radiol (NY); 2020 May; 45(5):1371-1386. PubMed ID: 31493022
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.
Guo C; Chen X; Wang Z; Xiao W; Wang Q; Sun K; Zhuge X
Oncotarget; 2017 Jun; 8(26):42962-42973. PubMed ID: 28487490
[TBL] [Abstract][Full Text] [Related]
18. DWI of Autoimmune Pancreatitis: Is It an Imaging Biomarker for Disease Activity?
Zhu L; Zhang W; Jin Z; Sun Z; Xue H; Denecke T; Hamm B; Lv H; Zhang S; Lai Y
AJR Am J Roentgenol; 2021 May; 216(5):1240-1246. PubMed ID: 33760653
[No Abstract] [Full Text] [Related]
19. Pancreatic duct "Icicle sign" on MRI for distinguishing autoimmune pancreatitis from pancreatic ductal adenocarcinoma in the proximal pancreas.
Kim HJ; Kim YK; Jeong WK; Lee WJ; Choi D
Eur Radiol; 2015 Jun; 25(6):1551-60. PubMed ID: 25501271
[TBL] [Abstract][Full Text] [Related]
20. Radiomics model of dual-time 2-[
Liu Z; Li M; Zuo C; Yang Z; Yang X; Ren S; Peng Y; Sun G; Shen J; Cheng C; Yang X
Eur Radiol; 2021 Sep; 31(9):6983-6991. PubMed ID: 33677645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
